Surgicure Technologies Announces $1.785 Million Seed Round to Revolutionize Airway Management
Summary
This investment will accelerate the commercialization of Surgicures flagship product, the Horseshoe, designed to improve the quality and safety of patient care across diverse medical settings.Founded in 2019 by Irena King, Surgicure Technologies is on a mission to reduce adverse events in airway management by introducing devices that optimize patient breathing and streamline clinical workflows. Originally invented by army respiratory therapists and now re-designed by Irena, the companys flagship product, the Horseshoe, is a novel patented solution for more reliable ET tube securement, prevention of facial pressure injuries, and more effective oral care. This technology not only improves clinical outcomes but also offers cost savings and device versatility in critical care, burn/trauma scenarios, and during evacuation or transport. "The industry is poised for disruption as the current practices for securing life-sustaining breathing tubes often rely on flimsy tape, leading to potential complications such as cardiac arrest, brain damage, and a 30% rate of preventable deaths. We believe Surgicure has the potential to set a new standard of care, and we are excited to partner with their talented team to help make that vision a reality.